T4K3.news
Annals rejects Kennedy retraction request
The journal will not retract the Danish aluminum vaccine study and cites no reason for retraction.

The editor of a leading medical journal declines RFK Jr.’s call to retract a Danish study on aluminum containing vaccines.
Annals rejects Kennedy retraction request on Danish aluminum vaccine study
The Annals of Internal Medicine has declined to retract the 2025 Danish study that found no link between childhood vaccines containing aluminum and 50 chronic health disorders. Editor in Chief Christine Laine said there is no reason for retraction. The work analyzed health records for about 1.2 million Danish children. Lead author Anders Hviid noted the study did not lack funding but faced critique about controls and data access; he said the country’s rules prevent releasing raw, individual level data. Kennedy has publicly questioned the study through an op ed on Trial Site News and targeted the research team and its funders. The op ed described the study as flawed and labeled the funding from the Novo Nordisk Foundation as a point of concern. The Danish data protection regime prevents sharing raw data, a fact critics say undermines transparency.
Key Takeaways
"I see no reason for retraction."
Laine on Kennedy's demand.
"None of the critiques put forward by the Secretary are substantive."
Hviid replying to Kennedy's critique.
"Flawed Science, Bought Conclusion: The Aluminum Vaccine Study the Media Won’t Question"
Kennedy's Trial Site News op ed headline.
The clash shows how science can become a channel for political fights. A journal’s decision to back a study under scrutiny tests the pressure journals face from officials who frame science as a political weapon. Trust in expertise may be endangered when funding and governance questions bleed into editorial choices. The episode also highlights how data access rules can complicate critique, even as lawmakers push for more openness in public health research.
Highlights
- Science must withstand political pressure and still speak truth
- Evidence should guide policy not headlines
- Credible research deserves credible scrutiny
- Public health demands calm transparent debate
Political backlash and funding shifts around vaccine science
The clash between a political figure, a medical journal, and a high profile vaccine study underscores how science can become a political battleground. The dispute touches on funding, data access, and public trust in health research.
The science debate will press on in classrooms, clinics, and courtrooms alike.
Enjoyed this? Let your friends know!
Related News

Capitol presence links Trump pick to January 6

Cruise declines Kennedy Center Honors invitation

China refuses US oil purchase demands

CDC funding faces new test

BMA blocks emergency requests for striking doctors

Tom Cruise declines Kennedy Center Honor

Gaynor Kennedy Center Honor Faces Political Backlash

Judge rejects Trump administration request to unseal Epstein transcripts
